322 related articles for article (PubMed ID: 32205809)
1. Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice?
Soria F; Giordano A; Gontero P
Curr Opin Urol; 2020 May; 30(3):370-376. PubMed ID: 32205809
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
Chen JC; Li T; Ning XH; Peng SH; Wang JY; Qi NN; Cai L; Gong K
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1124-7. PubMed ID: 27095782
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R
J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149
[No Abstract] [Full Text] [Related]
5. A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection.
Zhang KY; Xing JC; Li W; Wu Z; Chen B; Bai DY
World J Surg Oncol; 2017 Jul; 15(1):125. PubMed ID: 28683751
[TBL] [Abstract][Full Text] [Related]
6. En bloc resection of bladder tumors: challenges and unmet needs in 2022.
Symeonidis EN; Lo KL; Chui KL; Vakalopoulos I; Sountoulides P
Future Oncol; 2022 Jun; 18(20):2545-2558. PubMed ID: 35642479
[TBL] [Abstract][Full Text] [Related]
7. Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era.
Yanagisawa T; Kawada T; von Deimling M; Bekku K; Laukhtina E; Rajwa P; Chlosta M; Pradere B; D'Andrea D; Moschini M; Karakiewicz PI; Teoh JY; Miki J; Kimura T; Shariat SF
Eur Urol Focus; 2024 Jan; 10(1):41-56. PubMed ID: 37495458
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
[TBL] [Abstract][Full Text] [Related]
9. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Alsyouf M; Ladi-Seyedian SS; Konety B; Pohar K; Holzbeierlein JM; Kates M; Willard B; Taylor JM; Liao JC; Kaimakliotis HZ; Porten SP; Steinberg GD; Tyson MD; Lotan Y; Daneshmand S;
Urol Oncol; 2023 Feb; 41(2):109.e9-109.e14. PubMed ID: 36435710
[TBL] [Abstract][Full Text] [Related]
10. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
[TBL] [Abstract][Full Text] [Related]
11. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
12. Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
Yuk HD; Kim JK; Jeong CW; Kwak C; Kim HH; Ku JH
Biomed Res Int; 2018; 2018():9432606. PubMed ID: 30271788
[TBL] [Abstract][Full Text] [Related]
13. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
[TBL] [Abstract][Full Text] [Related]
14. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
15. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
16. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
[No Abstract] [Full Text] [Related]
17. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
18. Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.
Zapała P; Dybowski B; Poletajew S; Białek Ł; Niewczas A; Radziszewski P
World J Surg Oncol; 2018 Jan; 16(1):6. PubMed ID: 29334958
[TBL] [Abstract][Full Text] [Related]
19. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
[TBL] [Abstract][Full Text] [Related]
20. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
